Clinical Characteristics, Pathophysiology, and Management of Noncentral Nervous System Cancer-related Cognitive Impairment in Adults

Overview

Journal CA Cancer J Clin

Publisher Wiley

Specialty Oncology

Date 2014 Dec 9

PMID 25483452

Citations 230

Authors

Jeffrey S Wefel

Shelli R Kesler

Kyle R Noll

Sanne B Schagen

Affiliations

Soon will be listed here.

Abstract

Answer questions and earn CME/CNE Over the past few decades, a body of research has emerged confirming what many adult patients with noncentral nervous system cancer have long reported-that cancer and its treatment are frequently associated with cancer-related cognitive impairment (CRCI). The severity of CRCI varies, and symptoms can emerge early or late in the disease course. Nonetheless, CRCI is typically mild to moderate in nature and primarily involves the domains of memory, attention, executive functioning, and processing speed. Animal models and novel neuroimaging techniques have begun to unravel the pathophysiologic mechanisms underlying CRCI, including the role of inflammatory cascades, direct neurotoxic effects, damage to progenitor cells, white matter abnormalities, and reduced functional connectivity, among others. Given the paucity of research on CRCI with other cancer populations, this review synthesizes the current literature with a deliberate focus on CRCI within the context of breast cancer. A hypothetical case-study approach is used to illustrate how CRCI often presents clinically and how current science can inform practice. While the literature regarding intervention for CRCI is nascent, behavioral and pharmacologic approaches are discussed.

Citing Articles

Changes of perioperative cognitive function and its effect on quality of life in laryngeal cancer.

Gao Z, Jia L, Yao J, Wang C, Huang-Fu H Perioper Med (Lond). 2025; 14(1):28.

PMID: 40075433 PMC: 11905563. DOI: 10.1186/s13741-025-00507-x.

Longitudinal study of cognitive and mental functions among adult Hodgkin-lymphoma survivors, based on data from a primary treatment center in Hungary.

Virga I, Kosa K, Illes A, Miltenyi Z, Ivanka T, Berecz R Front Oncol. 2025; 15:1509424.

PMID: 40034597 PMC: 11872912. DOI: 10.3389/fonc.2025.1509424.

Direct effects of prolonged TNF-α and IL-6 exposure on neural activity in human iPSC-derived neuron-astrocyte co-cultures.

Goshi N, Lam D, Bogguri C, George V, Sebastian A, Cadena J Front Cell Neurosci. 2025; 19:1512591.

PMID: 40012566 PMC: 11860967. DOI: 10.3389/fncel.2025.1512591.

Efficacy of acupuncture in treating chemotherapy-related cognitive impairment in breast cancer patients: A systematic review and meta-analysis protocol.

Liu L, Meng Z, Yan J PLoS One. 2025; 20(2):e0318984.

PMID: 39913618 PMC: 11801641. DOI: 10.1371/journal.pone.0318984.

Effect of physical exercise on white matter microstructure in chemotherapy-treated breast cancer patients: a randomized controlled trial (PAM study).

Koevoets E, Schagen S, May A, Geerlings M, Witlox L, van der Wall E Brain Imaging Behav. 2025; .

PMID: 39804457 DOI: 10.1007/s11682-024-00965-9.

References

Hermelink K, Untch M, Lux M, Kreienberg R, Beck T, Bauerfeind I . Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer. 2007; 109(9):1905-13. DOI: 10.1002/cncr.22610. View

Gonzalez-Palau F, Franco M, Bamidis P, Losada R, Parra E, Papageorgiou S . The effects of a computer-based cognitive and physical training program in a healthy and mildly cognitive impaired aging sample. Aging Ment Health. 2014; 18(7):838-46. DOI: 10.1080/13607863.2014.899972. View

Deprez S, Vandenbulcke M, Peeters R, Emsell L, Smeets A, Christiaens M . Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints. J Clin Oncol. 2014; 32(19):2031-8. DOI: 10.1200/JCO.2013.53.6219. View

Helal G, Aleisa A, Helal O, Al-Rejaie S, Al-Yahya A, Al-Majed A . Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats. Oxid Med Cell Longev. 2010; 2(1):26-35. PMC: 2763228. DOI: 10.4161/oxim.2.1.7901. View

McDougall G, Becker H, Acee T, Vaughan P, Delville C . Symptom management of affective and cognitive disturbance with a group of cancer survivors. Arch Psychiatr Nurs. 2011; 25(1):24-35. PMC: 3057534. DOI: 10.1016/j.apnu.2010.05.004. View

Fabel K, Wolf S, Ehninger D, Babu H, Leal-Galicia P, Kempermann G . Additive effects of physical exercise and environmental enrichment on adult hippocampal neurogenesis in mice. Front Neurosci. 2010; 3:50. PMC: 2858601. DOI: 10.3389/neuro.22.002.2009. View

Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas K, Lachs M . Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc. 2006; 54(6):925-31. DOI: 10.1111/j.1532-5415.2006.00732.x. View

Briones T, Woods J, Wadowska M . Retracted: Involvement of insulin-like growth factor-1 in chemotherapy-related cognitive impairment. Behav Brain Res. 2014; 279:112-22. PMC: 4162858. DOI: 10.1016/j.bbr.2014.02.052. View

Vardy J . Cognitive function in breast cancer survivors. Cancer Treat Res. 2009; 151:387-419. DOI: 10.1007/978-0-387-75115-3_24. View

10.

Debess J, Riis J, Pedersen L, Ewertz M . Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark. Acta Oncol. 2008; 48(4):532-40. DOI: 10.1080/02841860802600755. View

11.

Boykoff N, Moieni M, Subramanian S . Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009; 3(4):223-32. PMC: 2775113. DOI: 10.1007/s11764-009-0098-x. View

12.

Dias G, Hollywood R, do Nascimento Bevilaqua M, da Luz A, Hindges R, Nardi A . Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms. Neuro Oncol. 2014; 16(4):476-92. PMC: 3956361. DOI: 10.1093/neuonc/not321. View

13.

Weiss H, Walker M, Wiernik P . Neurotoxicity of commonly used antineoplastic agents (first of two parts). N Engl J Med. 1974; 291(2):75-81. DOI: 10.1056/NEJM197407112910205. View

14.

Chincarini A, Bosco P, Calvini P, Gemme G, Esposito M, Olivieri C . Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease. Neuroimage. 2011; 58(2):469-80. DOI: 10.1016/j.neuroimage.2011.05.083. View

15.

Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D . The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study. Breast. 2005; 14(2):142-50. DOI: 10.1016/j.breast.2004.10.004. View

16.

Hayes S, Hayes J, Cadden M, Verfaellie M . A review of cardiorespiratory fitness-related neuroplasticity in the aging brain. Front Aging Neurosci. 2013; 5:31. PMC: 3709413. DOI: 10.3389/fnagi.2013.00031. View

17.

Gottschalk L, Holcombe R, Jackson D, Bechtel R . The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. Methods Find Exp Clin Pharmacol. 2003; 25(2):117-22. DOI: 10.1358/mf.2003.25.2.723685. View

18.

Shilling V, Jenkins V, Fallowfield L, Howell T . The effects of hormone therapy on cognition in breast cancer. J Steroid Biochem Mol Biol. 2003; 86(3-5):405-12. DOI: 10.1016/j.jsbmb.2003.07.001. View

19.

Sanoff H, Deal A, Krishnamurthy J, Torrice C, Dillon P, Sorrentino J . Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst. 2014; 106(4):dju057. PMC: 3982894. DOI: 10.1093/jnci/dju057. View

20.

McDonald B, Conroy S, Ahles T, West J, Saykin A . Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol. 2012; 30(20):2500-8. PMC: 3397784. DOI: 10.1200/JCO.2011.38.5674. View